Impact of cilostazol after endovascular treatment for infrainguinal disease in patients with critical limb ischemia Yoshimitsu Soga, MD, Osamu Iida,

Slides:

Advertisements

Similar presentations

The progressive nature of peripheral arterial disease in young adults: A prospective analysis of white men referred to a vascular surgery service R.James.

Advertisements

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Outcomes of cold-stored venous allograft for below-knee bypasses in patients with critical limb ischemia Vincent Ziza, MD, Ludovic Canaud, MD, PhD, Thomas.

Multidisciplinary care improves amputation-free survival in patients with chronic critical limb ischemia Jayer Chung, MD, J. Gregory Modrall, MD, Chul.

Autologous bone marrow mononuclear cell implantation therapy is an effective limb salvage strategy for patients with severe peripheral arterial disease

Favorable outcomes of very elderly patients with critical limb ischemia who undergo distal bypass surgery Takuro Shirasu, MD, Katsuyuki Hoshina, PhD,

Endovascular therapy for acute limb ischemia

Monica S. O'Brien-Irr, MS, RN, Hasan H. Dosluoglu, MD, Linda M

Revascularization for acute mesenteric ischemia

The association of chronic kidney disease and dialysis treatment with foot ulceration and major amputation Jeroen Otte, MD, MSc, Jaap J. van Netten,

Incidence, predictors, and prognosis of in-stent occlusion after endovascular treatment with nitinol stents for femoropopliteal lesions Tomoharu Dohi,

Benefit of immediate revascularization in women with critical limb ischemia in an intention-to-treat analysis Jana Ortmann, MD, Eveline Nüesch, PhD,

Smoking cessation is associated with decreased mortality and improved amputation- free survival among patients with symptomatic peripheral artery disease

Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia Andres.

IP181. Factors Affecting Limb Salvage Following Open and Endovascular Revascularization for Critical Limb Ischemia in a 10-Year Population-Based Study

The association of chronic kidney disease and dialysis treatment with foot ulceration and major amputation Jeroen Otte, MD, MSc, Jaap J. van Netten,

Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions Andrew M. Bakken, MD, Eugene Palchik, MD, Joseph P. Hart,

Revascularization for chronic critical lower limb ischemia in octogenarians is worthwhile Philippe Brosi, MD, Florian Dick, MD, Dai Do Do, MD, Juerg Schmidli,

Survival benefits of revascularization in patients with critical limb ischemia and renal insufficiency Jana Ortmann, MD, Brigitta Gahl, MD, Nicolas Diehm,

Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects) William R. Hiatt,

Early duplex scanning after infrainguinal endovascular therapy

Michael C. Stoner, MD, Dorian J. deFreitas, MD, Sachin V

Finnvasc score and modified Prevent III score predict long-term outcome after infrainguinal surgical and endovascular revascularization for critical limb.

Impaired renal function is associated with mortality and morbidity after endovascular abdominal aortic aneurysm repair Athanasios Saratzis, MBBS, MRCS,

Statin therapy is associated with superior clinical outcomes after endovascular treatment of critical limb ischemia Francesco A. Aiello, MD, Asad A.

Favorable outcomes of very elderly patients with critical limb ischemia who undergo distal bypass surgery Takuro Shirasu, MD, Katsuyuki Hoshina, PhD,

Michael S. Conte, MD Journal of Vascular Surgery

Endovascular abdominal aortic aneurysm repair: Long-term outcome measures in patients at high-risk for open surgery Gregorio A. Sicard, MD, Robert M.

Insulin use is associated with poor limb salvage and survival in diabetic patients with chronic limb ischemia Hasan H. Dosluoglu, MD, Purandath Lall,

Cost per day of patency: Understanding the impact of patency and reintervention in a sustainable model of healthcare Michael C. Stoner, MD, Dorian J.

Long-term results of direct and indirect endovascular revascularization based on the angiosome concept in patients with critical limb ischemia presenting.

Clinical efficacy of endovascular therapy for patients with critical limb ischemia attributable to pure isolated infrapopliteal lesions Osamu Iida, MD,

The consequences of an outbreak of multidrug-resistant Pseudomonas aeruginosa among patients treated for critical leg ischemia Maria Söderström, MD,

Effect of perioperative complications after endovascular therapy in patients with peripheral artery disease due to femoropopliteal lesions Kei Sato,

Surgical revascularization versus endovascular therapy for chronic mesenteric ischemia: A comparative experience Marvin D. Atkins, MD, Christopher J.

Katelynn M. Ferranti, MD, Turner M. Osler, MD, Reshma P

C-reactive protein and brain natriuretic peptide as predictors of adverse events after lower extremity endovascular revascularization Patrick A. Stone,

Outcomes of infrainguinal bypass determined by age in the Vascular Study Group of New England Meghan Dermody, MD, MS, Christopher Homsy, MD, Yuanyuan.

Current accepted hemodynamic criteria for critical limb ischemia do not accurately stratify patients at high risk for limb loss Raghuveer Vallabhaneni,

Clinical effects of single or double tibial artery revascularization in critical limb ischemia patients with tissue loss Norihiro Kobayashi, MD, Keisuke.

Daniel J. Torrent, MD, MPH, Jill N. Zink, MD, William M. Bogey, MD, C

Clinical effect of wound depth in critical limb ischemia with tissue loss after endovascular treatment Norihiro Kobayashi, MD, Keisuke Hirano, MD, Masatsugu.

Open versus endoscopic great saphenous vein harvest for lower extremity revascularization of critical limb ischemia Vincent J. Santo, MD, Phong T. Dargon,

Trends in the incidence, treatment, and outcomes of acute lower extremity ischemia in the United States Medicare population Donald T. Baril, MD, Kaushik.

Lower extremity arterial reconstruction for critical limb ischemia in diabetes Enzo Ballotta, MD, Antonio Toniato, MD, Giacomo Piatto, MD, Franco Mazzalai,

Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery Yoshimitsu.

Lower extremity autologous vein bypass for critical limb ischemia is not adversely affected by prior endovascular procedure Vincent J. Santo, MD, Phong.

Initial and 3-year results after subintimal versus intraluminal approach for long femoropopliteal occlusion treated with a self-expandable nitinol stent

A single-center experience in open and endovascular treatment of hemodynamically unstable and stable patients with ruptured abdominal aortic aneurysms

James T. McPhee, MD, Philip P

Determinants of mortality and treatment outcome following surgical interventions for acute mesenteric ischemia Panagiotis Kougias, MD, Donald Lau, BS,

Impact of wound blush as an angiographic end point of endovascular therapy for patients with critical limb ischemia Makoto Utsunomiya, MD, Masato Nakamura,

Lower extremity bypass vs endovascular therapy for young patients with symptomatic peripheral arterial disease Mauri J.A. Lepäntalo, MD, Rabih Houbballah,

Sequential compression biomechanical device in patients with critical limb ischemia and nonreconstructible peripheral vascular disease Sherif Sultan,

Jorg L. de Bruin, MD, Annette F. Baas, MD, PhD, Martijn W

The consequences of an outbreak of multidrug-resistant Pseudomonas aeruginosa among patients treated for critical leg ischemia Maria Söderström, MD,

Peripheral atherectomy in TransAtlantic InterSociety Consensus type C femoropopliteal lesions for limb salvage Andrea E. Yancey, MD, David J. Minion,

The Society for Vascular Surgery's objective performance goals for lower extremity revascularization are not generalizable to many open surgical bypass.

Anthony D. Whittemore, MD, Magruder C. Donaldson, MD, John A

Cassius Iyad Ochoa Chaar, MD, Michel S. Makaroun, MD, Luke K

Glauco Milio, MD, Chiara Minà, MD, Valentina Cospite, MD, Piero L

Christopher J. Abularrage, MD, Mark F. Conrad, MD, MMSc, Lauren A

Endovascular-first approach is not associated with worse amputation-free survival in appropriately selected patients with critical limb ischemia Karan.

Differences in anatomy and outcomes in patients treated with open mesenteric revascularization before and after the endovascular era Evan J. Ryer, MD,

Midterm outcomes of the Zenith Renu AAA Ancillary Graft

Prognosis of critical limb ischemia patients with tissue loss after achievement of complete wound healing by endovascular therapy Norihiro Kobayashi,

Outcomes of cold-stored venous allograft for below-knee bypasses in patients with critical limb ischemia Vincent Ziza, MD, Ludovic Canaud, MD, PhD, Thomas.

Endovascular brachytherapy for renal artery in-stent restenosis

J. David Neel, MD, Robin L. Kruse, PhD, Viktor Y

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Presentation transcript:

Impact of cilostazol after endovascular treatment for infrainguinal disease in patients with critical limb ischemia Yoshimitsu Soga, MD, Osamu Iida, MD, Keisuke Hirano, MD, Kenji Suzuki, MD, Daizo Kawasaki, MD, Yusuke Miyashita, MD, Taketsugu Tsuchiya, MD, Masakiyo Nobuyoshi, MD Journal of Vascular Surgery Volume 54, Issue 6, Pages 1659-1667 (December 2011) DOI: 10.1016/j.jvs.2011.06.024 Copyright © 2011 Society for Vascular Surgery Terms and Conditions

Fig 1 Kaplan-Meier curves show amputation-free survival rate in patients who did (+) and did not (–) receive cilostazol therapy. Journal of Vascular Surgery 2011 54, 1659-1667DOI: (10.1016/j.jvs.2011.06.024) Copyright © 2011 Society for Vascular Surgery Terms and Conditions

Fig 2 Kaplan-Meier curves show limb salvage rate in patients who did (+) and did not (–) receive cilostazol therapy. Journal of Vascular Surgery 2011 54, 1659-1667DOI: (10.1016/j.jvs.2011.06.024) Copyright © 2011 Society for Vascular Surgery Terms and Conditions

Fig 3 Kaplan-Meier curves show overall survival rate in patients who did (+) and did not (–) receive cilostazol therapy. Journal of Vascular Surgery 2011 54, 1659-1667DOI: (10.1016/j.jvs.2011.06.024) Copyright © 2011 Society for Vascular Surgery Terms and Conditions

Fig 4 Kaplan-Meier curves show freedom from cardiovascular death (CVD) in patients who did (+) and did not (–) receive cilostazol therapy. Journal of Vascular Surgery 2011 54, 1659-1667DOI: (10.1016/j.jvs.2011.06.024) Copyright © 2011 Society for Vascular Surgery Terms and Conditions

Fig 5 Kaplan-Meier curves show freedom from repeat revascularization in patients who did (+) and did not (–) receive cilostazol therapy. Journal of Vascular Surgery 2011 54, 1659-1667DOI: (10.1016/j.jvs.2011.06.024) Copyright © 2011 Society for Vascular Surgery Terms and Conditions

Fig 6 Univariate subgroup analysis shows amputation-free survival (AFS) in patients treated with cilostazol compared with those who did not receive cilostazol. Journal of Vascular Surgery 2011 54, 1659-1667DOI: (10.1016/j.jvs.2011.06.024) Copyright © 2011 Society for Vascular Surgery Terms and Conditions